The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Quedute 0.5 mg soft capsules

0.5 milligram(s) Capsule, soft

Rowex LtdPA0711/276/001

Main Information

Trade NameQuedute 0.5 mg soft capsules
Active SubstancesDutasteride
Strength0.5 milligram(s)
Dosage FormCapsule, soft
Licence HolderRowex Ltd
Licence NumberPA0711/276/001

Group Information

ATC CodeG04CB Testosterone-5-alpha reductase inhibitors
G04CB02 dutasteride

Status

Authorised/WithdrawnAuthorised
Licence Issued26/08/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back